SCM
RVNC
Sio Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-468,871
| Closed | -$2.31M | – | 61 |
|
|
2024
Q1 | $2.31M | Buy |
+468,871
| New | +$2.31M | 0.69% | 32 |
|
|
2023
Q4 | – | Sell |
-342,477
| Closed | -$3.93M | – | 60 |
|
|
2023
Q3 | $3.93M | Buy |
342,477
+200,977
| +142% | +$2.31M | 1.22% | 25 |
|
|
2023
Q2 | $3.58M | Buy |
+141,500
| New | +$3.58M | 0.91% | 18 |
|
|
2020
Q1 | – | Sell |
-87,700
| Closed | -$1.42M | – | 92 |
|
|
2019
Q4 | $1.42M | Sell |
87,700
-217,964
| -71% | -$3.54M | 0.34% | 42 |
|
|
2019
Q3 | $3.97M | Sell |
305,664
-98,000
| -24% | -$1.27M | 1.28% | 27 |
|
|
2019
Q2 | $5.24M | Buy |
403,664
+149,083
| +59% | +$1.93M | 1.26% | 21 |
|
|
2019
Q1 | $4.01M | Buy |
254,581
+86,857
| +52% | +$1.37M | 1.08% | 35 |
|
|
2018
Q4 | $3.38M | Buy |
167,724
+3,371
| +2% | +$67.9K | 1.23% | 34 |
|
|
2018
Q3 | $4.08M | Buy |
164,353
+63,061
| +62% | +$1.57M | 1.4% | 22 |
|
|
2018
Q2 | $2.78M | Buy |
+101,292
| New | +$2.78M | 1.54% | 25 |
|